Nabla Bio

Summer 2020Active

We use AI to design antibodies for intractable diseases

Save

Nabla Bio

Summer 2020Active

We use AI to design antibodies for intractable diseases

Save

Company details

Our mission is to enable pharmaceutical and biotech companies to bring more antibody therapies to patients. Using AI and massively parallel experimentation, we design antibodies that precisely bind the disease target at the right location, while minimizing manufacturability and toxicity risks. We are a well-funded, revenue-generating, bilingual company of wet- and dry-lab scientists, and are founded by AI and protein design experts from Harvard University.

Location

Boston, MA, USA

Founded

Unknown

Request the Nabla Bio report.

Nabla Bio has no report yet. Sign in with your email to request one.